Skip to main content
OncoTargets and Therapy logoLink to OncoTargets and Therapy
. 2023 Jul 7;16:543–544. doi: 10.2147/OTT.S429278

The Roles of Serum CXCL16 in Circulating Tregs and Gastrointestinal Stromal Tumor Cells [Retraction]

PMCID: PMC10335267  PMID: 37441364

Xing Y, Zhang J, Xu H. Onco Targets Ther. 2016;9:3939–3949.

We, the Editor and Publisher of OncoTargets and Therapy are retracting the published article. Concerns were raised following the authors request to correct images in Figure 3. It was found some of the images had been duplicated. Specifically,

  • Images from Figure 3C, Migration, Treg-C+S and Migration, GIST882-sorafenib have been duplicated.

  • Images from Figure 3C, Invasion, Treg and Migration, GIST-T1-sorafenib have been duplicated.

When approached for an explanation, the authors were cooperative but were unable to adequately address the concerns raised and could not provide sufficient supporting information. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors listed in this publication have been informed.

We have been informed in our decision-making by our editorial policies and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


Articles from OncoTargets and Therapy are provided here courtesy of Dove Press

RESOURCES